Current Hypertension Reports

Improvement of endothelial dysfunction as a surrogate endpoint in the treatment of hypertension

Teguh Santoso

Web alert

Literature alert

Review of recent framingham study hypertension research

William B. Kannel

Doxazosin arm of the ALLHAT study discontinued: How equal are antihypertensive drugs?

Franz H. Messerli, Ehud Grossman

Joint national committee VI: Individualized versus indiscriminate therapy for hypertension

Charles P. Tifft

The influence of national guidelines on antihypertensive prescribing patterns

David Siegel

Is there a preferred antihypertensive therapy for isolated systolic hypertension and reduced arterial compliance?

Stanley S. Franklin

Optimal antihypertensive therapy for prevention and treatment of left ventricular hypertrophy

Philip R. Liebson, Rod D. Serry

Diastolic pressure, systolic pressure, or pulse pressure?

Charalambos Vlachopoulos, Michael O’Rourke

Effects of antihypertensive therapy on hypertensive vascular disease

Jong Bae Park, Ernesto L. Schiffrin

Antihypertensive drug therapy in the third millennium: Are there benefits beyond blood pressure?

Stephen E. Bakir, Suzanne Oparil

Aldosterone-related genetic effects in hypertension

David G. Warnock

Central nervous system norepinephrine metabolism in hypertension

Gavin W. Lambert

Interaction between leptin and sympathetic nervous system in hypertension

William G. Haynes

Role of the sympathetic nervous system in human renovascular hypertension

Mats Johansson, Peter Friberg

Aldosterone and vascular damage

Daniel Duprez, Marc De Buyzere, Ernst R. Rietzschel, Denis L. Clement

Treatment of hypertension in diabetes mellitus

Alejandro de la Sierra, Luis Miguel Ruilope